Log in

Start Your Membership Now

On June 13 (Japan time), Otsuka Pharmaceutical and IBM Japan finalized an agreement to establish Otsuka Digital Health Co., Ltd. (Otsuka Digital Health), a joint venture independent of Otsuka’s pharmaceutical business, in order to start a digital health solutions business for psychiatry in Japan. Otsuka Digital Health will market MENTAT, which was developed based on Otsuka’s knowledge and expertise in the central nervous system and on IBM’s Watson-based technology. The company will integrate and analyze a large volume of data held by medical institutions. Solutions will be provided for medical issues such as improving the quality . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Merger & Acquisitions

Categories
All Bulletins
Submit a Bulletin
  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.